Hugo platform

New platform to allow patients to become partners in research

Called Hugo, the platform was developed to allow people to acquire their health-related data as well as use it to participate in studies.
Breakthrough app

Walgreens unveils MDLIVE-powered behavioral telehealth platform

Together with Mental Health America, the company aims to screen 3 million people through 2017; it will also offer resources to those in need.
MouthWatch teledentistry

MouthWatch unveils teledentistry solution

Using TeleDent, providers can offer both asynchronous evaluations and live video conferencing, including both radiographic and intraoral images.
Move Data Forward Challenge

ONC unveils Move Data Forward Challenge with $250K in prizes

The challenge invites interested parties to create an API to allow people to securely authorize the movement of their health data to destinations they choose.
Dr. Patrick Soon-Shiong

NantHealth looking to raise $92M in an IPO

The Culver City, California-based company has developed a platform, called CLINICS, to address many of the key challenges healthcare constituents face.
Sweatcoin

This app will help Brits walk and run more

Sweatcoin allows users to earn digital currency for their steps and later use their earnings to purchase real-world products and services.
Eliza app

The Eliza app aims to make mental health tracking easy, available to everyone

The app asks users to record a voice memo, then turns the speech into text that's ready for sentiment analysis, and returns an easy to grasp infographic.
AliveCor

Small study shows AliveCor’s smartphone ECG is as good as standard Holter monitor

The study involved patients already wearing the standard Holter ambulatory event monitor with AliveCor's device being added to the mix.
Fitbit

Fitbit Q1 revenues hit $505M for a 50% Y-o-Y growth

During Q1, Fitbit sold 4.8 million connected health and fitness devices. U.S. comprised 70% of revenues, EMEA - 15%, APAC - 11%, and Other Americas - 4%.
Project EVO - ADHD study

Akili starts recruiting patients to trial its novel ADHD treatment

The STARS-ADHD trial will evaluate the safety and efficacy of the company's proprietary platform, Project: EVO, for the treatment of children with ADHD.